Journals / Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni / 2022 / Cilt: 13 - Sayı: 3

IS IT POSSIBLE FOR PULMONER ARTERIAL DIROFILARIASIS TO BE TREATED? TREATMENT OPTIONS FROM PAST TO PRESENT

PULMONER ARTERİYAL DİROFİLARİASİS TEDAVİ EDİLEBİLİR Mİ? GEÇMİŞTEN GÜNÜMÜZE TEDAVİ SEÇENEKLERİ

Pages
174–186
Publication Date
2022-12-31
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this review, it might be tried to give information about the treatment and prevention of pulmoner arterial dirofilariasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Pulmoner arterial dirofilariasis, especially in domestic/wild dogs and cats, is a severe disease that can result in death by frequently localizing to the pulmonary and circulatory system.
📊
Key Findings & Data:The prevalence of the agent has increased with the change of climates in the world; therefore, the disease has gained importance.
💡
Conclusion & Impact:In this review, it might be tried to give information about the treatment and prevention of pulmoner arterial dirofilariasis.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Dirofilaria immitis · Korunma · Köpek

Abstract

Pulmoner arterial dirofilariasis, especially in domestic/wild dogs and cats, is a severe disease that can result in death by frequently localizing to the pulmonary and circulatory system. The prevalence of the agent has increased with the change of climates in the world; therefore, the disease has gained importance. In recent years, different drug/drug combinations and treatment protocols have been studied to treat dirofilariasis and prevent the disease. In this review, it might be tried to give information about the treatment and prevention of pulmoner arterial dirofilariasis.

Özet

Pulmoner arteriyal dirofilariasis, özellikle evcil/yabani köpek ve kedilerde sıklıkla pulmoner sistem ve dolaşım sistemine yerleşim göstererek ölümle sonuçlanabilen zoonoz karakterde bir filarial nematod enfeksiyonudur. Dünyada iklimlerin değişmesiyle etkenin yaygınlığı artmış ve bu nedenle hastalık önem kazanmıştır. Dirofilarisisi tedavi etmek ve hastalıktan korunmak için son yıllarda farklı ilaç/ilaç kombinasyonları ve tedavi protokolleri üzerinde çalışılmaktadır. Bu derlemede, pulmoner arteriyal dirofilariasisin tedavisi ve hastalıktan korunma yolları hakkında bilgiler verilmeye çalışılmıştır.

🔖

Cite This Article

YALÇIN, D. S., IŞIK, N. (2022). IS IT POSSIBLE FOR PULMONER ARTERIAL DIROFILARIASIS TO BE TREATED? TREATMENT OPTIONS FROM PAST TO PRESENT. Veteriner Farmakoloji ve Toksikoloji Derneği Bülteni, Cilt: 13 - Sayı: 3, 174–186. https://ajindex.com/articles/872401

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Abraham, D. (1988).
  2. Biology of Dirofilaria immitis. In, Boreham PFL, Atwell RB. Editors. Dirofilariasis. 2nd ed. USA: CRC Press; 1988. pp. 30-46.
  3. American Heartworm Society (2020). Prevention, diagnosis and management of Heartworm (Dirofilaria immitis) infection in dogs. American Heartworm Society Canine Guidelines. Erişim adresi: https://d3ft8sckhnqim2.cloudfront.net/images/pdf/2020_AHS_Canine_Guidelines.pdf?1580934824.
  4. Atwell, R. B. & Tarish J. H. (1995). The effect of oral, low-dose prednisolone on the extent of pulmonary pathology associated with dead Dirofilaria immitis in a canine lung model. Proceedings of the Heartworm Symposium ’95, Auburn, AL, USA, 1995, 103-111.
  5. Bandi, C., McCall, J. W., Genchi, C., Corona, S., Venco, L. & Sacchi, L. (1999). Effects of tetracycline on the filarial worms Brugia pahangi and Dirofilaria immitis and their bacterial endosymbionts Wolbachia. Int J Parasitol, 29, 357-364. doi:10.1016/s0020-7519(98)00200-8.
  6. Bazzocchi, C., Mortarino, M., Grandi, G., Kramer, L. H., Genchi, C., Bandi, C., Genchi, M., Sacchi, L. & McCall, J. W. (2008). Combined ivermectin and doxycycline treatment has microfilaricidal and adulticidal activity against Dirofilaria immitis in experimentally infected dogs. Int J Parasitol, 38, 1401-1410. doi: 10.1016/j.ijpara.2008.03.002. Blagburn, B., Dillon, R., Prichard, R., Geary, T., Mount, J., Land, T., Butler, J. & Bourguinat, C. (2010). Characterization of Heartworm Prevention Failures in the Central United States [abstract]. Proceedings of the State of the Heartworm Symposium ‘10, Batavia, IL, USA, 2010, 27–28.
  7. Blagburn, B. L. & Dillon, A. R. (2007). Feline heartworm disease: solving the puzzle. Vet Med, 102 (l), 7-14.
  8. Boudreaux, M., Dillon, A. R., Ravis, W. R., Sartin, E. A. & Spano, J. S. (1991). Effects of treatment with aspirin or aspirin/dipyridamole combination in heartworm-negative, heartworm infected, and embolized heartworm–infected dogs. Am J Vet Res, 52 (12), 1992-1999.
  9. Bowman, D. D. & Atkins, C. E. (2009). Heartworm biology, treatment, and control. Vet Clin North Am Small Anim Pract, 39 (6), 1127–1158.
  10. Bowman, D. D. & Mannella, C. (2011). Macrocyclic lactones and Dirofilaria immitis microfilariae. Top Companion Anim Med, 26 (4), 160-172. doi:10.1053/j.tcam.2011.07.001. Börkü, M. K., Kurtdede, A., Azizoğlu, D. & Kilit, M. (1996). Dirofilaria immitis ile doğal enfekte köpeklerde thiacetarsamide sodium uygulamaları. Ankara Üniv Vet Fak Derg, 43, 247-256.
  11. Chandrashekar, R., Beall, M. J., Saucie